AngioDynamics (ANGO) Competitors $10.65 -0.31 (-2.83%) Closing price 04:00 PM EasternExtended Trading$10.49 -0.16 (-1.49%) As of 05:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ANGO vs. TMO, WST, IART, OFIX, SRDX, ARAY, RMTI, RSLS, ABT, and ISRGShould you be buying AngioDynamics stock or one of its competitors? The main competitors of AngioDynamics include Thermo Fisher Scientific (TMO), West Pharmaceutical Services (WST), Integra LifeSciences (IART), Orthofix Medical (OFIX), Surmodics (SRDX), Accuray (ARAY), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), and Intuitive Surgical (ISRG). These companies are all part of the "medical" sector. AngioDynamics vs. Its Competitors Thermo Fisher Scientific West Pharmaceutical Services Integra LifeSciences Orthofix Medical Surmodics Accuray Rockwell Medical ReShape Lifesciences Abbott Laboratories Intuitive Surgical Thermo Fisher Scientific (NYSE:TMO) and AngioDynamics (NASDAQ:ANGO) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, media sentiment, profitability, dividends, analyst recommendations, institutional ownership, earnings and risk. Do analysts recommend TMO or ANGO? Thermo Fisher Scientific currently has a consensus price target of $592.24, suggesting a potential upside of 23.52%. AngioDynamics has a consensus price target of $19.00, suggesting a potential upside of 78.40%. Given AngioDynamics' stronger consensus rating and higher probable upside, analysts clearly believe AngioDynamics is more favorable than Thermo Fisher Scientific.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Thermo Fisher Scientific 0 Sell rating(s) 5 Hold rating(s) 17 Buy rating(s) 0 Strong Buy rating(s) 2.77AngioDynamics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is TMO or ANGO more profitable? Thermo Fisher Scientific has a net margin of 15.24% compared to AngioDynamics' net margin of -11.62%. Thermo Fisher Scientific's return on equity of 16.82% beat AngioDynamics' return on equity.Company Net Margins Return on Equity Return on Assets Thermo Fisher Scientific15.24% 16.82% 8.38% AngioDynamics -11.62%-3.20%-2.09% Does the media favor TMO or ANGO? In the previous week, Thermo Fisher Scientific had 59 more articles in the media than AngioDynamics. MarketBeat recorded 63 mentions for Thermo Fisher Scientific and 4 mentions for AngioDynamics. AngioDynamics' average media sentiment score of 1.78 beat Thermo Fisher Scientific's score of 1.32 indicating that AngioDynamics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Thermo Fisher Scientific 44 Very Positive mention(s) 5 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive AngioDynamics 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has more volatility & risk, TMO or ANGO? Thermo Fisher Scientific has a beta of 0.75, suggesting that its stock price is 25% less volatile than the S&P 500. Comparatively, AngioDynamics has a beta of 0.64, suggesting that its stock price is 36% less volatile than the S&P 500. Which has preferable earnings and valuation, TMO or ANGO? Thermo Fisher Scientific has higher revenue and earnings than AngioDynamics. AngioDynamics is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioThermo Fisher Scientific$43.21B4.19$6.34B$17.2927.73AngioDynamics$292.50M1.48-$33.99M-$0.83-12.83 Do institutionals & insiders have more ownership in TMO or ANGO? 89.2% of Thermo Fisher Scientific shares are owned by institutional investors. Comparatively, 89.4% of AngioDynamics shares are owned by institutional investors. 0.3% of Thermo Fisher Scientific shares are owned by company insiders. Comparatively, 5.4% of AngioDynamics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. SummaryThermo Fisher Scientific beats AngioDynamics on 11 of the 16 factors compared between the two stocks. Get AngioDynamics News Delivered to You Automatically Sign up to receive the latest news and ratings for ANGO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ANGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ANGO vs. The Competition Export to ExcelMetricAngioDynamicsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$432.75M$6.79B$5.79B$10.15BDividend YieldN/A1.23%5.69%4.61%P/E Ratio-12.8325.5274.5925.92Price / Sales1.4862.89454.0285.55Price / Cash22.4621.6337.0859.91Price / Book2.365.0012.156.29Net Income-$33.99M$176.38M$3.28B$270.85M7 Day Performance-0.75%1.00%0.98%3.35%1 Month Performance20.48%3.19%7.20%6.40%1 Year Performance41.81%12.30%63.06%28.21% AngioDynamics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ANGOAngioDynamics4.1675 of 5 stars$10.65-2.8%$19.00+78.4%+47.7%$432.75M$292.50M-12.83760Positive NewsTMOThermo Fisher Scientific4.9749 of 5 stars$493.05+0.7%$593.00+20.3%-20.6%$186.06B$42.88B28.52125,000Trending NewsAnalyst UpgradeInsider TradeAnalyst RevisionWSTWest Pharmaceutical Services4.977 of 5 stars$247.18+0.7%$320.71+29.7%-12.8%$17.76B$2.89B37.0010,600News CoveragePositive NewsIARTIntegra LifeSciences4.1703 of 5 stars$15.13+2.0%$18.43+21.8%-12.1%$1.18B$1.61B-2.324,396Positive NewsOFIXOrthofix Medical3.4884 of 5 stars$14.98+1.6%$21.50+43.5%-13.8%$591.62M$799.49M-4.731,616News CoveragePositive NewsSRDXSurmodics4.6105 of 5 stars$34.04-0.8%$43.00+26.3%-17.7%$486.69M$126.08M-27.67450Positive NewsARAYAccuray4.7101 of 5 stars$1.52-2.6%$5.00+228.9%-19.3%$171.27M$458.51M-76.001,040Positive NewsRMTIRockwell Medical3.7982 of 5 stars$1.71-5.0%$4.00+133.9%-58.8%$58.88M$101.49M-28.50300Short Interest ↑Gap UpHigh Trading VolumeRSLSReShape Lifesciences0.0139 of 5 stars$3.16-1.4%N/A-99.7%$8.49M$8.01M-0.0350Gap DownHigh Trading VolumeABTAbbott Laboratories4.8837 of 5 stars$132.59+0.9%$144.47+9.0%+13.7%$230.89B$41.95B16.61114,000Positive NewsISRGIntuitive Surgical4.9359 of 5 stars$473.30-0.1%$595.95+25.9%-7.1%$169.67B$8.35B66.0115,638News CoveragePositive News Related Companies and Tools Related Companies Thermo Fisher Scientific Competitors West Pharmaceutical Services Competitors Integra LifeSciences Competitors Orthofix Medical Competitors Surmodics Competitors Accuray Competitors Rockwell Medical Competitors ReShape Lifesciences Competitors Abbott Laboratories Competitors Intuitive Surgical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ANGO) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored6-Figure Target for BTC by 2025Crypto ETF records broken – here's what’s next The biggest names in finance have built the infrastructure f...Crypto 101 Media | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredThe $17B signal no one expected…After SpaceX struck a $17 billion deal with EchoStar for a block of radio frequencies, tech analyst Jeff Brown...Brownstone Research | SponsoredWall Street laughed at Trump’s “Smart Dollar.” Now they’re all in."THIS is the Biggest Economic Story of 2025" While most Americans are focused on tariffs and inflation, the...Stansberry Research | SponsoredTrump’s new AI budget just passed — one stock could soarIn a quiet move few people noticed... President Trump just green-lit what could become the biggest AI budge...Behind the Markets | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AngioDynamics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AngioDynamics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
